| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.20B | +6.8% |
| Cost of Revenue | $1.20B | +2.8% |
| Gross Profit | $1.00B | +12.0% |
| R&D Expense | $16.9M | +15.8% |
| SG&A Expense | $587.5M | +6.9% |
| Operating Income | $230.1M | +155.5% |
| Interest Expense | $106.7M | +1.4% |
| Pre-tax Income | $91.3M | +624.6% |
| Income Tax | $49.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.7M | -86.7% |
| Accounts Receivable | $444.4M | +39.6% |
| Inventory | $962.4M | +30.0% |
| Current Assets | $1.57B | -2.3% |
| Total Assets | $4.05B | +6.2% |
| Current Liabilities | $384.8M | +23.2% |
| Long-term Debt | $1.77B | +6.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.6M | -186.6% |
| Capital Expenditures | $56.7M | +1.7% |
| Investing Cash Flow | -$422.4M | -174.0% |
| Financing Cash Flow | $100.6M | +138.7% |
| Free Cash Flow | -$124.3M | -657.5% |
| +129.8% |
| Net Income | $12.8M | -94.8% |
| EPS (Diluted) | -$1.14 | -146.3% |
| Total Liabilities |
| $2.49B |
| +8.3% |
| Stockholders' Equity | $1.30B | -2.3% |